Dhaval Nanavati is a Principal Scientist I at AbbVie, with experience leading initiatives in neuroscience, immunology, and cancer biology, focusing on metadata analysis of large data sets. Key contributions include the comprehensive characterization of endogenous targets, advancing mass spectrometry for biotherapeutics, and developing analytical pipelines for glycosylation profiles. Previous roles include Senior Scientist II at AbbVie and Director of the Proteomics Core at Northwestern University, where operational management and collaboration with faculty were emphasized. Dhaval also served as a Postdoctoral Researcher at the National Institute of Mental Health and holds a Ph.D. in Microbiology from the University of Connecticut.
January, 2019 - present
February, 2016